Datametrex AI (TSXV: DM) appears to have a sales pipeline in the mining sector. This morning the company announced that it has been awarded a tender by an undisclosed Quebec-based mining firm for the supply of an initial 2,000 COVID-19 test kits, its second such arrangement with a mining operation.
The supply arrangement entered into by Datametrex will see the mining firm utilize detection kits manufactured by 1drop Inc, with all related testing to be provided through Datametrex’s strategic partnership with Transpharm Canada. That partnership essentially allows the firm to offer a full suite of testing products and services, enabling a smooth process for the client.
All of the required test kits for the order have already been secured from the manufacturer, and will be shipped directly to that of Transpharm whom will conduct all necessary testing. As is the typical case, Datametrex anticipates having little to not upfront costs associated with the transaction.
By offering security technologies, Datametrex reaffirms its commitment to its customers, shareholders, families, and the Canadian public. We sincerely hope to aid in the reopening of businesses and social and cultural events in a safe and economic way
Marshall Gunter, CEO of Datametrex
A timeline for the delivery of the products was not provided, however it is anticipated to close in the near term.
Datametrex AI last traded at $0.12 on the TSX Venture.
FULL DISCLOSURE: Datametrex AI is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Datametrex AI on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
